- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- October 2024
- 188 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
Nizatidine is a medication used to treat gastrointestinal disorders, such as acid reflux and peptic ulcers. It is a histamine H2-receptor antagonist, which works by blocking the action of histamine on the cells in the stomach, reducing the production of stomach acid. It is available in both prescription and over-the-counter forms.
Nizatidine is used to treat a variety of gastrointestinal disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. It is also used to prevent and treat ulcers caused by the use of nonsteroidal anti-inflammatory drugs (NSAIDs). It is generally well-tolerated, with few side effects.
Nizatidine is available in a variety of forms, including tablets, capsules, and oral suspensions. It is marketed by several pharmaceutical companies, including Pfizer, GlaxoSmithKline, and Merck. It is also available in generic forms.
In the Nizatidine market, companies such as Pfizer, GlaxoSmithKline, and Merck are major players. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more